Cincinnati, OH, United States of America

Frank P Zemlan



Average Co-Inventor Count = 1.4

ph-index = 3

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 1995-2008

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Frank P. Zemlan: Innovator in Neurological Treatments

Introduction

Frank P. Zemlan is a notable inventor based in Cincinnati, OH (US), recognized for his contributions to the field of mental health and neurological disorders. He holds a total of 5 patents, showcasing his innovative approach to addressing complex medical challenges.

Latest Patents

Zemlan's latest patents include a method for treating various mental disorders, including attention deficit hyperactivity disorder (ADHD), alcohol addiction, and anxiety disorders. This invention involves administering a therapeutically effective, nontoxic dose of a 4',4″-substituted 3α-(diphenylmethoxy) tropane analog or its pharmaceutically acceptable salt to patients in need. Another significant patent focuses on detecting axonal damage associated with neurological diseases using tau monoclonal antibodies. This method aids in diagnosing patients with axonal degeneration, particularly in cases of head trauma or CNS tumors.

Career Highlights

Throughout his career, Zemlan has worked with esteemed organizations such as the University of Cincinnati and Phase 2 Discovery, Inc. His work has significantly impacted the understanding and treatment of neurological conditions, contributing to advancements in medical science.

Collaborations

Zemlan has collaborated with notable colleagues, including Jeffrey Mulchahey and Thomas A. Campbell, further enhancing the scope and impact of his research.

Conclusion

Frank P. Zemlan's innovative work in the field of mental health and neurology exemplifies the importance of research and development in improving patient care. His patents reflect a commitment to finding effective solutions for complex medical issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…